JP2020191853A - 健康補助食品 - Google Patents
健康補助食品 Download PDFInfo
- Publication number
- JP2020191853A JP2020191853A JP2019101469A JP2019101469A JP2020191853A JP 2020191853 A JP2020191853 A JP 2020191853A JP 2019101469 A JP2019101469 A JP 2019101469A JP 2019101469 A JP2019101469 A JP 2019101469A JP 2020191853 A JP2020191853 A JP 2020191853A
- Authority
- JP
- Japan
- Prior art keywords
- saffron
- dietary supplement
- containing material
- lactic acid
- gaba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000015872 dietary supplement Nutrition 0.000 title claims abstract description 95
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims abstract description 117
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 84
- 244000124209 Crocus sativus Species 0.000 claims abstract description 61
- 235000015655 Crocus sativus Nutrition 0.000 claims abstract description 61
- 235000013974 saffron Nutrition 0.000 claims abstract description 61
- 239000004248 saffron Substances 0.000 claims abstract description 61
- 239000000463 material Substances 0.000 claims abstract description 55
- 241000894006 Bacteria Species 0.000 claims abstract description 45
- 239000004310 lactic acid Substances 0.000 claims abstract description 42
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 42
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims abstract description 41
- 108010016626 Dipeptides Proteins 0.000 claims abstract description 39
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims abstract description 39
- 229940002508 ginger extract Drugs 0.000 claims description 31
- 235000020708 ginger extract Nutrition 0.000 claims description 31
- 241000234314 Zingiber Species 0.000 abstract description 6
- 235000006886 Zingiber officinale Nutrition 0.000 abstract description 6
- 235000008397 ginger Nutrition 0.000 abstract description 6
- 230000009471 action Effects 0.000 abstract description 4
- 241000756137 Hemerocallis Species 0.000 abstract 1
- 238000000605 extraction Methods 0.000 abstract 1
- 239000000843 powder Substances 0.000 description 48
- 230000000694 effects Effects 0.000 description 43
- 241000209094 Oryza Species 0.000 description 29
- 235000007164 Oryza sativa Nutrition 0.000 description 29
- 235000009566 rice Nutrition 0.000 description 29
- 239000000284 extract Substances 0.000 description 24
- 241000287828 Gallus gallus Species 0.000 description 12
- 235000021329 brown rice Nutrition 0.000 description 11
- 239000001599 crocus sativus l. flower extract Substances 0.000 description 8
- 210000000936 intestine Anatomy 0.000 description 8
- 229940076591 saffron extract Drugs 0.000 description 8
- 229920001353 Dextrin Polymers 0.000 description 7
- 239000004375 Dextrin Substances 0.000 description 7
- 230000017531 blood circulation Effects 0.000 description 7
- 235000019425 dextrin Nutrition 0.000 description 7
- 239000000546 pharmaceutical excipient Substances 0.000 description 7
- 239000002994 raw material Substances 0.000 description 7
- 241000282414 Homo sapiens Species 0.000 description 6
- 210000004556 brain Anatomy 0.000 description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
- 208000020401 Depressive disease Diseases 0.000 description 5
- 229920002774 Maltodextrin Polymers 0.000 description 5
- 239000005913 Maltodextrin Substances 0.000 description 5
- 229920002472 Starch Polymers 0.000 description 5
- 239000000654 additive Substances 0.000 description 5
- 239000002775 capsule Substances 0.000 description 5
- JSKZWIGBDHYSGI-UCSXVCBISA-L disodium;(6r,7r)-7-[[(2e)-2-(2-amino-1,3-thiazol-4-yl)-2-[1-[2-(3,4-dihydroxybenzoyl)hydrazinyl]-2-methyl-1-oxopropan-2-yl]oxyiminoacetyl]amino]-3-[(2-carboxylato-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2. Chemical compound [Na+].[Na+].N([C@H]1[C@@H]2N(C1=O)C(=C(CS2)CSC1=CC(=NC2=NC(=NN21)C([O-])=O)C)C([O-])=O)C(=O)C(\C=1N=C(N)SC=1)=N\OC(C)(C)C(=O)NNC(=O)C1=CC=C(O)C(O)=C1 JSKZWIGBDHYSGI-UCSXVCBISA-L 0.000 description 5
- 229940035034 maltodextrin Drugs 0.000 description 5
- 235000019698 starch Nutrition 0.000 description 5
- 239000008107 starch Substances 0.000 description 5
- SLRNWACWRVGMKD-UHFFFAOYSA-N L-anserine Natural products CN1C=NC(CC(NC(=O)CCN)C(O)=O)=C1 SLRNWACWRVGMKD-UHFFFAOYSA-N 0.000 description 4
- 230000004630 mental health Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- 235000019359 magnesium stearate Nutrition 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 2
- SLRNWACWRVGMKD-QMMMGPOBSA-N Balenine Chemical compound CN1C=NC(C[C@H](N=C(O)CCN)C(O)=O)=C1 SLRNWACWRVGMKD-QMMMGPOBSA-N 0.000 description 2
- SEBIKDIMAPSUBY-ARYZWOCPSA-N Crocin Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)C(C)=CC=CC(C)=C\C=C\C=C(/C)\C=C\C=C(C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SEBIKDIMAPSUBY-ARYZWOCPSA-N 0.000 description 2
- SEBIKDIMAPSUBY-JAUCNNNOSA-N Crocin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C=CC=C(/C)C(=O)OC3OC(COC4OC(CO)C(O)C(O)C4O)C(O)C(O)C3O SEBIKDIMAPSUBY-JAUCNNNOSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 229920002527 Glycogen Polymers 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 108010084730 N(beta)-alanyl-1-methyl-histidine Proteins 0.000 description 2
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 description 2
- 206010034203 Pectus Carinatum Diseases 0.000 description 2
- MYYIAHXIVFADCU-QMMMGPOBSA-N anserine Chemical compound CN1C=NC=C1C[C@H](NC(=O)CC[NH3+])C([O-])=O MYYIAHXIVFADCU-QMMMGPOBSA-N 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 description 2
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 210000004211 gastric acid Anatomy 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 229940096919 glycogen Drugs 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 239000002075 main ingredient Substances 0.000 description 2
- 230000006996 mental state Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- -1 terpene alcohols Chemical class 0.000 description 2
- 235000007586 terpenes Nutrition 0.000 description 2
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- AFQPSLVGGMCBOR-JLTXGRSLSA-N 2-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-18-(2,2-dimethyl-6-methylidenecyclohexyl)-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaenyl]-1,3,3-trimethylcyclohexene Chemical compound C\C(\C=C\C=C(/C)\C=C\C1C(=C)CCCC1(C)C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C)CCCC1(C)C AFQPSLVGGMCBOR-JLTXGRSLSA-N 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 108010085443 Anserine Proteins 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 206010003840 Autonomic nervous system imbalance Diseases 0.000 description 1
- 241000193749 Bacillus coagulans Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 description 1
- 108010087806 Carnosine Proteins 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- PANKHBYNKQNAHN-JTBLXSOISA-N Crocetin Natural products OC(=O)C(\C)=C/C=C/C(/C)=C\C=C\C=C(\C)/C=C/C=C(/C)C(O)=O PANKHBYNKQNAHN-JTBLXSOISA-N 0.000 description 1
- 244000163122 Curcuma domestica Species 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241001113425 Iridaceae Species 0.000 description 1
- 240000001929 Lactobacillus brevis Species 0.000 description 1
- 235000013957 Lactobacillus brevis Nutrition 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- WMHJCSAICLADIN-MVVLZTAMSA-N Picrocrocin Natural products O=CC=1C(C)(C)C[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O2)CC=1C WMHJCSAICLADIN-MVVLZTAMSA-N 0.000 description 1
- 241000210053 Potentilla elegans Species 0.000 description 1
- 229920001131 Pulp (paper) Polymers 0.000 description 1
- 241000269851 Sarda sarda Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000032140 Sleepiness Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 206010042209 Stress Diseases 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 241000234299 Zingiberaceae Species 0.000 description 1
- 235000006822 akino wasuregusa Nutrition 0.000 description 1
- 244000307585 akino wasuregusa Species 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229940054340 bacillus coagulans Drugs 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229940044199 carnosine Drugs 0.000 description 1
- PANKHBYNKQNAHN-JUMCEFIXSA-N carotenoid dicarboxylic acid Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)O)C=CC=C(/C)C(=O)O PANKHBYNKQNAHN-JUMCEFIXSA-N 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 210000004720 cerebrum Anatomy 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- PANKHBYNKQNAHN-MQQNZMFNSA-N crocetin Chemical compound OC(=O)C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)C(O)=O PANKHBYNKQNAHN-MQQNZMFNSA-N 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- 235000012754 curcumin Nutrition 0.000 description 1
- 239000004148 curcumin Substances 0.000 description 1
- 229940109262 curcumin Drugs 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 235000021186 dishes Nutrition 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229940124600 folk medicine Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 210000001320 hippocampus Anatomy 0.000 description 1
- 229960002885 histidine Drugs 0.000 description 1
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 235000021109 kimchi Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 235000021110 pickles Nutrition 0.000 description 1
- WMHJCSAICLADIN-WYWSWGBSSA-N picrocrocin Chemical compound C1C(C)=C(C=O)C(C)(C)C[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 WMHJCSAICLADIN-WYWSWGBSSA-N 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 229930182852 proteinogenic amino acid Natural products 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 230000037321 sleepiness Effects 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Images
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
- Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
- Y02P60/87—Re-use of by-products of food processing for fodder production
Abstract
Description
先ず、健康補助食品を構成する原材料が用意される。具体的には、その原材料として、サフラン末、クワンソウ末、有胞子性乳酸菌、米ぬか発酵粉末、チキンエキス末(粉末状のイミダゾールジペプチド含有素材)、黒生姜エキス末、及び、賦形剤が、それぞれ所定量用意される。
上記の実施形態で説明した要件の一つ以上は、省略される場合がある。
10A 上面
10B 下面
Claims (3)
- クワンソウ、GABA含有素材、イミダゾールジペプチド含有素材、及び黒生姜エキスのいずれか一つ以上に、有胞子乳酸菌を含有させ、サフランをさらに含有させた健康補助食品。
- クワンソウ、有胞子乳酸菌、イミダゾールジペプチド含有素材、及び黒生姜エキスのいずれか一つ以上に、GABA含有素材を含有させ、サフランをさらに含有させた健康補助食品。
- クワンソウ、有胞子乳酸菌、GABA含有素材、及び黒生姜エキスのいずれか一つ以上に、イミダゾールジペプチド含有素材を含有させ、サフランをさらに含有させた健康補助食品。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019101469A JP7307467B2 (ja) | 2019-05-30 | 2019-05-30 | 健康補助食品 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019101469A JP7307467B2 (ja) | 2019-05-30 | 2019-05-30 | 健康補助食品 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2020191853A true JP2020191853A (ja) | 2020-12-03 |
JP7307467B2 JP7307467B2 (ja) | 2023-07-12 |
Family
ID=73545471
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019101469A Active JP7307467B2 (ja) | 2019-05-30 | 2019-05-30 | 健康補助食品 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP7307467B2 (ja) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006160697A (ja) * | 2004-12-10 | 2006-06-22 | Kao Corp | 睡眠健康改善剤 |
JP2015110564A (ja) * | 2013-11-08 | 2015-06-18 | マルハニチロ株式会社 | 概日リズム改善剤 |
JP2016210703A (ja) * | 2015-04-30 | 2016-12-15 | 株式会社東洋新薬 | 時計遺伝子発現促進用組成物 |
-
2019
- 2019-05-30 JP JP2019101469A patent/JP7307467B2/ja active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006160697A (ja) * | 2004-12-10 | 2006-06-22 | Kao Corp | 睡眠健康改善剤 |
JP2015110564A (ja) * | 2013-11-08 | 2015-06-18 | マルハニチロ株式会社 | 概日リズム改善剤 |
JP2016210703A (ja) * | 2015-04-30 | 2016-12-15 | 株式会社東洋新薬 | 時計遺伝子発現促進用組成物 |
Non-Patent Citations (3)
Title |
---|
"GABA Tablet, ID#:4036419", MINTEL GNPD [ONLINE], JPN6023009856, May 2016 (2016-05-01), ISSN: 0005026755 * |
"Sleep Pro Dietary Supplement, ID#:6193347", MINTEL GNPD [ONLINE], JPN6023009857, December 2018 (2018-12-01), ISSN: 0005026754 * |
"さくらの森 SUYARi スヤリ おやすみサプリ 30粒", AMAZON.CO.JP [ONLINE], JPN6022045709, 11 April 2019 (2019-04-11), ISSN: 0005026753 * |
Also Published As
Publication number | Publication date |
---|---|
JP7307467B2 (ja) | 2023-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105918821A (zh) | 具有降三高并提高免疫力功能的综合酵素液及其制备方法 | |
CN105054167A (zh) | 一种红枣风味谷物饮料及其制备方法 | |
CN104286273A (zh) | 铁皮石斛的用途及其茶叶制品 | |
CN107927512A (zh) | 一种低聚肽减肥代餐固体饮料 | |
CN107535790A (zh) | 一种西红花人参颗粒饮品、其制备方法和应用 | |
CN104116117B (zh) | 一种减肥保健饮料 | |
CN104188009A (zh) | 一种银杏核桃花生露及其制备方法 | |
CN101715989B (zh) | 一种营养鸡汤冻及其制做方法 | |
JP4459540B2 (ja) | 機能性健康飲食品 | |
CN105124669A (zh) | 一种清肠理气的燕麦苦荞饮料及其制备方法 | |
CN103988911A (zh) | 一种黑土豆水牛奶乳制品及其制备方法 | |
CN106107954A (zh) | 一种芝麻方便食品及其加工方法 | |
KR100871568B1 (ko) | 식물성 건강 음료 및 그 제조방법 | |
JP7307467B2 (ja) | 健康補助食品 | |
CN109938252A (zh) | 一种抗衰老、降血糖的食叶草米排粉及其制备方法 | |
KR20170006616A (ko) | 한방약재를 이용한 닭백숙의 제조방법 및 이를 통해 제조된 닭백숙 | |
CN104687118A (zh) | 营养型减肥速溶粉 | |
JP5320573B2 (ja) | 鯉エキスの製造方法、およびそれを利用した鯉エキス栄養補給食品 | |
CN107904124A (zh) | 一种黑豆醋的生产工艺 | |
CN106072505A (zh) | 一种酸辣杏鲍菇脯 | |
JP2020061954A (ja) | 健康補助食品 | |
KR20050045666A (ko) | 비만억제 조성물 | |
CN107173562A (zh) | 一种包括白芨的中药羊饲料及其制备方法 | |
CN107136260A (zh) | 保健茶及其制备方法与应用 | |
CN107432304A (zh) | 荞麦马铃薯糕点的加工方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20211206 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20221021 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20221101 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20221227 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230404 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230407 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20230620 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20230623 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7307467 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |